Examples of such potential biomarkers include CD16 expression associated with anti-HIV activity as demonstrated by our group [64,72] as well as increased NKG2A expression linked to hyperresponsive anti-tumor function as recently shown by Cazzetta et al. [19]. The gene discussed is KLRC1; the disease is neoplasm.